Search clinical trials for: Brentuximab vedotin
Total 412 results
-
The Lymphoma Academic Research OrganisationCompletedRefractory Peripheral T-Cell Lymphoma | Relapsed Peripheral T-Cell LymphomaFrance, Belgium
-
Federal Research Institute of Pediatric Hematology...RecruitingHodgkin's LymphomaRussian Federation
-
Fondazione Italiana Linfomi ONLUSCompleted
-
University of CologneRecruitingClassical Hodgkin LymphomaGermany
-
University of BirminghamMillennium Pharmaceuticals, Inc.; Leukaemia Lymphoma ResearchCompleted
-
Arbeitsgemeinschaft medikamentoese TumortherapieTerminatedALK+ Anaplastic Large Cell LymphomaAustria
-
Jason Robert GotlibSeagen Inc.CompletedSystemic Mastocytosis | Mast Cell Leukemia | Aggressive Systemic MastocytosisUnited States
-
SethiMerck Sharp & Dohme LLCRecruitingT-Cell LymphomaUnited States
-
Bristol-Myers SquibbOno Pharmaceutical Co. Ltd; Seagen Inc.Terminated
-
Nabil AdraTerminatedNonseminomatous Germ Cell Tumor | Testis Cancer | Testicular Cancer | Embryonal Carcinoma | Germ Cell TumorsUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Seagen Inc.Completed
-
Fondazione Italiana Linfomi ONLUSCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteSeagen Inc.TerminatedPilot Study of Brentuximab Vedotin in Relapsed/Refractory Peripheral T-Cell Lymphoma Expressing CD30Peripheral T-Cell LymphomaUnited States
-
Lawson Health Research InstituteSeagen Inc.RecruitingDiffuse Cutaneous Systemic SclerosisCanada
-
Washington University School of MedicineCelgene; Seagen Inc.CompletedLymphoma, Large B-Cell, DiffuseUnited States
-
Seagen Inc.Merck Sharp & Dohme LLCRecruitingMelanoma | Squamous Cell Carcinoma of the Head and Neck | Non-small Cell Lung CancerUnited States, Canada
-
University of Kansas Medical CenterSeagen Inc.Recruiting
-
Stichting Hemato-Oncologie voor Volwassenen NederlandRecruiting
-
Fondazione MichelangeloFondazione IRCCS Istituto Nazionale dei Tumori, Milano; Millennium Pharmaceuticals...CompletedGerm Cell CancerItaly
-
M.D. Anderson Cancer CenterTerminated
-
Eric Bernicker, MDMillennium Pharmaceuticals, Inc.; The Methodist Hospital Research InstituteWithdrawnCD30-positive Lymphoma | CD30-positive Solid TumorUnited States
-
Hospital Regional de Alta Especialidad del BajioUniversidad de GuanajuatoRecruitingHodgkin Lymphoma | Refractory Hodgkin Lymphoma | Relapsed Hodgkin's Disease, AdultMexico
-
Millennium Pharmaceuticals, Inc.CompletedHodgkin LymphomaPoland, Spain, Malaysia, Turkey, Germany, Czechia, Thailand
-
Fondazione Italiana Linfomi ONLUSCompletedPrimary Mediastinal Large B Cell LymphomaItaly
-
Peter MacCallum Cancer Centre, AustraliaCompletedHodgkin Lymphoma | Lymphoma, T-Cell, Cutaneous | Lymphoma, T-Cell, PeripheralAustralia
-
Fox Chase Cancer CenterCelgene Corporation; Seagen Inc.Active, not recruitingCutaneous T-cell Lymphoma (CTCL)United States
-
Seagen Inc.Active, not recruitingDiffuse Large B-cell LymphomaUnited States, France, Australia, Czechia, Italy, Spain, Canada, Belgium, Korea, Republic of, United Kingdom, Poland, Denmark, Germany, Netherlands, Switzerland, Taiwan
-
University Hospital Inselspital, BerneMundipharma Medical CompanyRecruiting
-
Seagen Inc.TerminatedLymphoma, Non-Hodgkin | Lymphoma, Large-Cell, Anaplastic | Disease, HodgkinUnited States
-
Seagen Inc.CompletedAnaplastic Large-Cell LymphomaUnited States
-
Bristol-Myers SquibbSeagen Inc.Active, not recruitingHodgkin DiseaseUnited Kingdom, United States, Poland, Spain, Canada, Czechia, France, Germany, Ireland, Italy, Netherlands
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedRecurrent Hodgkin Lymphoma | Refractory Hodgkin LymphomaUnited States
-
Imagine InstituteTakedaCompletedEnteropathy Associated T-cell LymphomaFrance
-
Universitätsmedizin MannheimKlinikum Ludwigshafen; Wuerzburg University Hospital; KKS Netzwerk; Klinikum Minden and other collaboratorsCompletedCutaneous T Cell LymphomaGermany
-
Seagen Inc.Bristol-Myers SquibbCompletedHodgkin Disease | Peripheral T Cell LymphomaUnited States, Canada
-
Seagen Inc.RecruitingLymphoma, Large B-Cell, Diffuse | Lymphoma, Non-Hodgkin | Hodgkin Disease | Lymphoma, T-Cell, Cutaneous | Lymphoma, T-Cell, Peripheral | Lymphoma, Large-Cell, AnaplasticUnited States
-
Bristol-Myers SquibbSeagen Inc.CompletedNon-Hodgkin's DiseaseUnited States, France, Canada, United Kingdom, Italy, Spain
-
University of CataniaCompletedHaemostasis | Fibrin Sealant
-
Millennium Pharmaceuticals, Inc.CompletedHodgkin Lymphoma | Anaplastic Large-cell LymphomaSpain, Belgium, Lithuania
-
M.D. Anderson Cancer CenterTakedaWithdrawnAnaplastic Large Cell Lymphoma | Classical Hodgkin Lymphoma | Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic | CD30+ Peripheral T-cell Lymphoma
-
TakedaRecruitingHodgkin LymphomaJapan
-
Seagen Inc.RecruitingLymphoma, Large B-Cell, Diffuse | Hodgkin Disease | Lymphoma, T-Cell, Peripheral | Lymphoma, Large-Cell, AnaplasticUnited States
-
Western Regional Medical CenterWithdrawnLymphoma | Hodgkin's Lymphoma | Non-hodgkin's LymphomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Seagen Inc.WithdrawnHematopoietic/Lymphoid CancerUnited States
-
Fred Hutchinson Cancer Research Center/University...National Cancer Institute (NCI)WithdrawnGraft Versus Host DiseaseUnited States
-
New York Medical CollegeSt. Baldrick's FoundationActive, not recruiting
-
University of ArizonaWithdrawnFollicular Lymphoma | Marginal Zone Lymphoma | Diffuse Large B Cell Lymphoma | Small Lymphocytic Lymphoma | Mediastinal Large B-cell Lymphoma | Grey Zone Lymphoma | High Grade B Cell LymphomaUnited States
-
TakedaTerminatedErosive EsophagitisChina
-
TakedaActive, not recruitingHodgkin DiseaseUnited States, Italy, Brazil, Japan
-
UNC Lineberger Comprehensive Cancer CenterSeagen Inc.Active, not recruitingLymphoma | Lymphatic Diseases | Adult T-Cell Leukemia/LymphomaUnited States